| 9857359 |
Methods for determining drug efficacy using cereblon-associated proteins |
Peter Schafer, Rajesh Chopra, Antonia Lopez-Girona, Maria Yinglin Wang, Pilgrim Jackson |
2018-01-02 |
| 9000132 |
Lipoprotein-associated phospholipase A2 antibody compositions and methods of use |
Paul Levi Miller |
2015-04-07 |
| 8637260 |
Phosphorylated RaIA |
William C. Hahn, Anna A. Sablina |
2014-01-28 |
| 8394832 |
Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders |
Weiming Xu |
2013-03-12 |
| 8207311 |
Ovr115 antibody compositions and methods of use |
Glenn Pilkington, Gilbert-Andre Keller, Wenlu Li, Iris Simon |
2012-06-26 |
| 8148093 |
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
Iris Simon, Charis Lawrenson, Nam Hoon Kim, Glenn Pilkington, Robert L. Wolfert |
2012-04-03 |
| 8080650 |
Pro104 antibody compositions and methods of use |
Jackie Papkoff, Glenn Pilkington, Gilbert-Andre Keller, Wenlu Li, Iris Simon +2 more |
2011-12-20 |
| 7619068 |
Ovr110 antibody compositions and methods of use |
Glenn Pilkington, Gilbert-Andre Keller, Wenlu Li, Iris Simon, Jackie Papkoff |
2009-11-17 |
| 7479546 |
Pro104 antibody compositions and methods of use |
Jackie Papkoff, Glenn Pilkington, Gilbert-Andre Keller, Wenlu Li, Iris Simon +2 more |
2009-01-20 |
| 7294704 |
Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
Iris Simon, Charis Lawrenson, Nam Hoon Kim, Glenn Pilkington, Robert L. Wolfert |
2007-11-13 |